Nanoparticles Destroy Disease Proteins: Dementia & Cancer Breakthrough
- Researchers have developed a nanoparticle system capable of selectively removing harmful proteins from the body, perhaps offering treatment options for diseases previously considered untreatable, such as dementia and...
- The new approach centers around nanoparticles engineered to bind to specific target proteins.
- According to the research article, the nanoparticles are coated with a substance that mimics the body's own proteins, allowing them to circulate without triggering an immediate immune response.
Nanoparticle Technology Targets ‘Undruggable’ Proteins
Table of Contents
Researchers have developed a nanoparticle system capable of selectively removing harmful proteins from the body, perhaps offering treatment options for diseases previously considered untreatable, such as dementia and brain cancer. The findings were published in Nature Nanotechnology on January 22, 2026.
How the Nanoparticles Work
The new approach centers around nanoparticles engineered to bind to specific target proteins. Once bound, these nanoparticles trigger the body’s natural clearance mechanisms to remove the harmful proteins. This differs from conventional drug progress, which often struggles with proteins lacking suitable binding sites for conventional medications. The technology circumvents the need for a drug to directly interact with the protein to inhibit its function; rather, it focuses on eliminating the protein altogether.
According to the research article, the nanoparticles are coated with a substance that mimics the body’s own proteins, allowing them to circulate without triggering an immediate immune response. This extended circulation time is crucial for effectively locating and binding to the target proteins.
Potential Applications in Dementia Treatment
Dementia, including Alzheimer’s disease, is often characterized by the buildup of misfolded proteins like amyloid-beta and tau. These proteins disrupt brain function and contribute to neuronal damage. The nanoparticle technology offers a potential pathway to remove these toxic proteins, slowing or even reversing disease progression.
Researchers at the National Institute on Aging have identified amyloid-beta and tau as key targets for therapeutic intervention. A report by the Alzheimer’s Association estimates that 6.7 million Americans are currently living with Alzheimer’s disease,highlighting the urgent need for new treatment strategies.
Implications for Brain Cancer Therapy
Certain brain cancers produce proteins that promote tumor growth and suppress the immune system. Removing these proteins could enhance the effectiveness of existing cancer therapies and improve patient outcomes. The nanoparticle system’s ability to selectively target and eliminate these proteins represents a notable advancement.
The National Cancer Institute reports that approximately 24,810 new cases of brain and other nervous system cancers are expected to be diagnosed in the United States in 2026. Current treatment options, including surgery, radiation, and chemotherapy, often have limited efficacy and significant side effects. This new technology could provide a more targeted and less invasive approach.
Future Research and Development
While the initial results are promising, further research is needed to assess the long-term safety and efficacy of this nanoparticle technology.Clinical trials are planned to evaluate its potential in treating various diseases.Researchers are also working to refine the nanoparticles to improve their targeting specificity and enhance their ability to cross the blood-brain barrier.
the research team, lead by Dr. Evelyn Hayes at the Massachusetts Institute of Technology, received a National Institutes of Health grant of $5 million in December 2025 to support these ongoing investigations.